Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01260584Phase 4Completed
A Phase 4 trial of prasugrel in coronary artery disease (CAD), sponsored by Daiichi Sankyo Co., Ltd.. Started Nov 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01260584.